en

PRODUCT DETAIL

Truxima 500 mg infúzny koncentrát

Code 3163C
MA number EU/1/16/1167/001
Product Form: con inf 1x50 ml/500 mg (liek inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
L01FA CD20 (Clusters of Differentiation 20) inhibitors
L01FA01 Rituximab
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 17.02.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 22.02.2022
eu-flag.png sk-flag.png